首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Design, characterization and in vitro evaluation of novel amphiphilic block sunflower oil-based polyol nanocarrier as a potential delivery system: Raloxifene-hydrochloride as a model
【24h】

Design, characterization and in vitro evaluation of novel amphiphilic block sunflower oil-based polyol nanocarrier as a potential delivery system: Raloxifene-hydrochloride as a model

机译:新型两亲块葵花籽油基多元醇纳米骨载体的设计,表征和体外评价作为潜在递送系统:盐酸雷洛昔芬 - 盐酸盐作为模型

获取原文
获取原文并翻译 | 示例
       

摘要

Presently, modern pharmaceuticals, are almost exclusively derived from the arduous refining of petroleum whose supply is inherently unsustainable. In order to address this issue bio-based materials are increasingly being used for chemical synthesis, particularly in drug delivery systems. Biodegradable and biocompatible hyper-branched polyol (an alcohol containing three or more hydroxyl groups) was synthesized via a facile method through the ring-opening and thiol-ene click reactions at room temperature. Due to the bio-based content of the polyol backbone, the synthesized polyol had both excellent biodegradability and low cytotoxicity. Raloxifene hydrochloride, an oral selective estrogen receptor modulator, was used as a hydrophobic drug model to test the potential of polyol as a drug delivery system carrier. Polyol showed an amphiphilic character and could be prepared as a nanoparticle for the sustained delivery of raloxifene hydrochloride, a drug with poor bioavailability in aqueous solution. Raloxifene hydrochloride was readily encapsulated in the lipophilic core of polyol whose branched hydroxyls were on the external part of the prepared nanoparticles. The diameter of the nanoparticles was 94 +/- 0.43 nm, their drug entrapment efficiency was 93 +/- 0.5% and they showed a sustained release profile (17 +/- 1.5% after 4 weeks). The 3-(4,5-dimethylthiazol-2-y1)-5-(3-carboxymethoxypheny1)-2-(4-sulfopheny1)-2H-tetrazolium (MTS) assay showed low toxicity towards human osteoblast MG-63 cells. Based on its good biodegradability and low cytotoxicity, polyol provides a bio-based source for the design new drug delivery systems. (C) 2017 Elsevier B.V. All rights reserved.
机译:目前,现代制药,几乎完全来自于石油的艰苦精炼,其供应本质上是不可持续的。为了解决这个问题,生物基材料越来越多地用于化学合成,特别是在药物递送系统中。通过环开口和硫醇-NEE在室温下咔哒反应,通过容纳方法合成可生物降解和生物相容性的超分支多元醇(含有三个或更多个羟基)的醇。由于多元醇骨架的生物基含量,合成的多元醇具有优异的生物降解性和低细胞毒性。一种口服选择性雌激素受体调节剂的盐酸雷洛昔芬盐酸盐作为疏水性药物模型,以测试多元醇作为药物递送系统载体的潜力。多元醇显示两亲性质,可以制备为纳米颗粒,用于盐酸雷洛昔芬盐酸雷洛昔芬盐酸盐持续递送,在水溶液中具有差的生物利用度差。盐酸雷洛昔芬盐酸盐易于包封在多元醇的亲脂核中,其支化羟基在制备纳米颗粒的外部。纳米颗粒的直径为94 +/- 0.43nm,它们的药物夹带效率为93 +/- 0.5%,它们显示出持续的释放曲线(4周后17 +/- 1.5%)。 3-(4,5-二甲基噻唑-2- y1)-5-(3-羧甲氧基氧基苯基1)-2-(4-磺苯酚1)-2H-四唑(MTS)测定显示对人骨盆Mg-63细胞的低毒性。基于其良好的生物降解性和低细胞毒性,多元醇提供了一种用于设计新药递送系统的生物源。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号